Depression and anxiety are on the rise but front-line treatments aren’t always effective. Explore emerging approaches to mental health care including transcranial magnetic stimulation, psilocybin and ketamine, and separate science from hype.
Dr. Jeffrey Eisen, Chief Medical Officer, Cascadia Behavioral Healthcare
Dr. Jonathan Horey, Chief Medical Officer, Active Recovery TMS
Dr. Sandhya Prashad, Medical Director, Houston Ketamine Theraptics, President, American Society of Ketamine Physicians
Dr. Anthony Bossis, NYU School of Medicine, Clinical Assistant Professor and Director of Palliative Care Research for the NYU Psilocybin Cancer Anxiety Study
Dane Fickes, PharmD, MBA, Genoa Healthcare Pharmacist and Site Manager
A recording of the webinar presentation can be found here.